HLA-DR and CD34 negativity is a distinctive feature of “AML-cuplike” with FLT3-ITD [6] and in AML-M1 and AML-M2 subtypes with NPM1 mutation [7]. This evidence concerns the gene NPM1 and acute myeloid leukemia.